Type A Aortic Dissection in Marfan Syndrome

  • Bartosz Rylski
    From the Division of Cardiothoracic Surgery, Hospital of the University of Pennsylvania in Philadelphia (BR., J.E.B., E.B., N.D.D., R.K.M., W.Y.S., P.V.); and Department of Cardiovascular Surgery, Heart Center Freiburg University, Freiburg, Germany (B.R., F.B., M.S., F.A.K.).
  • Joseph E. Bavaria
    From the Division of Cardiothoracic Surgery, Hospital of the University of Pennsylvania in Philadelphia (BR., J.E.B., E.B., N.D.D., R.K.M., W.Y.S., P.V.); and Department of Cardiovascular Surgery, Heart Center Freiburg University, Freiburg, Germany (B.R., F.B., M.S., F.A.K.).
  • Friedhelm Beyersdorf
    From the Division of Cardiothoracic Surgery, Hospital of the University of Pennsylvania in Philadelphia (BR., J.E.B., E.B., N.D.D., R.K.M., W.Y.S., P.V.); and Department of Cardiovascular Surgery, Heart Center Freiburg University, Freiburg, Germany (B.R., F.B., M.S., F.A.K.).
  • Emanuela Branchetti
    From the Division of Cardiothoracic Surgery, Hospital of the University of Pennsylvania in Philadelphia (BR., J.E.B., E.B., N.D.D., R.K.M., W.Y.S., P.V.); and Department of Cardiovascular Surgery, Heart Center Freiburg University, Freiburg, Germany (B.R., F.B., M.S., F.A.K.).
  • Nimesh D. Desai
    From the Division of Cardiothoracic Surgery, Hospital of the University of Pennsylvania in Philadelphia (BR., J.E.B., E.B., N.D.D., R.K.M., W.Y.S., P.V.); and Department of Cardiovascular Surgery, Heart Center Freiburg University, Freiburg, Germany (B.R., F.B., M.S., F.A.K.).
  • Rita K. Milewski
    From the Division of Cardiothoracic Surgery, Hospital of the University of Pennsylvania in Philadelphia (BR., J.E.B., E.B., N.D.D., R.K.M., W.Y.S., P.V.); and Department of Cardiovascular Surgery, Heart Center Freiburg University, Freiburg, Germany (B.R., F.B., M.S., F.A.K.).
  • Wilson Y. Szeto
    From the Division of Cardiothoracic Surgery, Hospital of the University of Pennsylvania in Philadelphia (BR., J.E.B., E.B., N.D.D., R.K.M., W.Y.S., P.V.); and Department of Cardiovascular Surgery, Heart Center Freiburg University, Freiburg, Germany (B.R., F.B., M.S., F.A.K.).
  • Prashanth Vallabhajosyula
    From the Division of Cardiothoracic Surgery, Hospital of the University of Pennsylvania in Philadelphia (BR., J.E.B., E.B., N.D.D., R.K.M., W.Y.S., P.V.); and Department of Cardiovascular Surgery, Heart Center Freiburg University, Freiburg, Germany (B.R., F.B., M.S., F.A.K.).
  • Matthias Siepe
    From the Division of Cardiothoracic Surgery, Hospital of the University of Pennsylvania in Philadelphia (BR., J.E.B., E.B., N.D.D., R.K.M., W.Y.S., P.V.); and Department of Cardiovascular Surgery, Heart Center Freiburg University, Freiburg, Germany (B.R., F.B., M.S., F.A.K.).
  • Fabian A. Kari
    From the Division of Cardiothoracic Surgery, Hospital of the University of Pennsylvania in Philadelphia (BR., J.E.B., E.B., N.D.D., R.K.M., W.Y.S., P.V.); and Department of Cardiovascular Surgery, Heart Center Freiburg University, Freiburg, Germany (B.R., F.B., M.S., F.A.K.).

書誌事項

タイトル別名
  • Extent of Initial Surgery Determines Long-Term Outcome

説明

<jats:sec> <jats:title>Background—</jats:title> <jats:p>Data on outcomes after Stanford type A aortic dissection in patients with Marfan syndrome are limited. We investigated the primary surgery and long-term results in patients with Marfan syndrome who suffered aortic dissection.</jats:p> </jats:sec> <jats:sec> <jats:title>Methods and Results—</jats:title> <jats:p>Among 1324 consecutive patients with aortic dissection type A, 74 with Marfan syndrome (58% men; median age, 37 years [first and third quartiles, 29 and 48 years]) underwent surgical repair (85% acute dissections; 68% DeBakey I; 55% composite valved graft, 30% supracoronary ascending replacement, 15% valve-sparing aortic root replacement; 12% total arch replacement; 3% in-hospital mortality) at 2 tertiary centers in the United States and Europe over the past 25 years. The rate of aortic reintervention with resternotomy was 24% (18 of 74) and of descending aorta (thoracic+abdominal) intervention was 30% (22 of 74) at a median follow-up of 8.4 years (first and third quartiles, 2.2 and 12.7 years). Freedom from need for aortic root reoperation in patients who underwent primarily a composite valved graft or valve-sparing aortic root replacement procedure was 95±3%, 88±5%, and 79±5% and in patients who underwent supracoronary ascending replacement was 83±9%, 60±13%, 20±16% at 5, 10, and 20 years. Secondary aortic arch surgery was necessary only in patients with initial hemi-arch replacement.</jats:p> </jats:sec> <jats:sec> <jats:title>Conclusions—</jats:title> <jats:p>Emergency surgery for type A dissection in patients with Marfan syndrome is associated with low in-hospital mortality. Failure to extend the primary surgery to aortic root or arch repair leads to a highly complex clinical course. Aortic root replacement or repair is highly recommended because supracoronary ascending replacement is associated with a high need (>40%) for root reintervention.</jats:p> </jats:sec>

収録刊行物

  • Circulation

    Circulation 129 (13), 1381-1386, 2014-04

    Ovid Technologies (Wolters Kluwer Health)

被引用文献 (3)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ